Mycoplasma Bovis in Bison 2022 Case Control Study

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
eICR 2022 Mbovis SS A (20220507).docx	Supporting Statement A	Uploaded 2022-04-11	Available
OMB Approval to Collect Info for Bison Producers.pdf	Supplementary Document	Uploaded 2022-03-30	Available
eICR 2022 Mbovis APHIS 79.xlsx	Supplementary Document	Uploaded 2022-03-30	Available
eICR 2022 Mbovis APHIS 71.xlsx	Supplementary Document	Uploaded 2022-03-30	Repair queued
eICR 2022 MBovis SS B.docx	Supporting Statement B	Uploaded 2022-03-30	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
252451	Private Sector	Other-survey	New

ICR Details

OMB Control No: 0579-0482	ICR Reference No: 202203-0579-005
Status: Active	Previous ICR Reference No:
Agency/Subagency: USDA/APHIS	Agency Tracking No:
Title: Mycoplasma Bovis in Bison 2022 Case Control Study
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Emergency	Approval Requested By: 04/15/2022
OIRA Conclusion Action: Approved without change	Conclusion Date: 04/12/2022
	Date Received in OIRA: 04/12/2022
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	10/31/2022	6 Months From Approved
Responses	220	0	0
Time Burden (Hours)	55	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: This study will collect information needed to identify risk factors for the rapidly spreading pathogen Mycoplasma bovis in bison. Identifying these risk factors is critical for developing disease prevention and control recommendations.

Emergency Justfication: This study will generate information needed to identify risk factors for the rapidly spreading pathogen Mycoplasma bovis in bison herds. Identifying the risk factors is critical for developing disease prevention and control recommendations. These recommendations are necessary because there are no effective treatments or vaccines currently for this pathogen and resulting mortality losses are high and recurring. The result for bison producers is significant economic losses, cultural losses for Native American tribes, and threatening conservation efforts for the Nation’s wild bison populations.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Private Sector

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	220	0	0	220	0	0
Annual Time Burden (Hours)	55	0	0	55	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This is a new information collection package needed to develop countermeasures for Mycoplasma Bovis disease outbreak in U.S. bison herds.

---

Annual Cost to Federal Government: $34,983

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 04/12/2022

---